NATIONAL SPEAKER

Sabrina Burgener is a mid-career immunologist and Team Leader in Prof. Schroder Inflammasome Lab at the University of Queensland. Sabrina has 12 years of experience in serine and cysteine proteases, cell death pathways and innate immune signalling, and translate this expertise into preclinical disease models. Here research vision is to discover how inflammasome signalling boosts disease progression and comprehensively define the multilayered regulation of this immune complex in this complex disease, integrating experimental research directly with future clinical applications. To achieve this, she is leading an innovative and multidisciplinary research program that will define disease-driving mechanisms in chronic low-grade diseases such as metabolic liver disease, with several first and last author outputs in international recognised field-specific journals, including Nature Immunology, Cell Reports, Journal of Experimental Medicine, and Cold Spring Harbour Perspectives in Biology, etc. Her research output reflects their exceptional skill set, with a major focus on state-of-the-art technologies in biochemistry and molecular biology to address disease driving mechanism in preclinical disease models. Their research contributions are internationally recognised with several international awards, supported by prestigious back-to-back Fellowships (2018-2023) and competitive project funding, including ARC Discovery Projects as CIA and CIB with a strong collaborative mindset nationally and internationally.